BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor (World)
Ablynx (ABLYF) Announces Warrant Exercise 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Nine-Month Figures For 2014: Sartorius Grows In Order Intake, Sales Revenue And Earnings 10/21/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts 10/21/2014
Tianyin Pharmaceutical Co, Inc. Received Notices Of Non-Compliance From NYSE MKT 10/21/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt 10/21/2014
DBV Technologies Announces Proposed Global Offering 10/20/2014
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment 10/20/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014
TiGenix Publishes Transparency Notification Pursuant To Article 14 Of The Law Of May 2, 2007 10/17/2014
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000 10/16/2014
Tianyin Pharmaceutical Co, Inc. Provides Update On Filing Of Form 10-K For Fiscal Year Ended June 30, 2014 10/15/2014
Orexo AB (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2014/2015 10/15/2014
Announcement Regarding Submission Of Tender Offer For Shares In Ambit Biosciences 10/15/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma 10/15/2014
Immunodiagnostic Systems Holdings plc Trading Update 10/14/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014
Nextech Venture Invest Announces First Closing Of Oncology Fund IV 10/14/2014
Easton Pharmaceuticals (OP: EAPH) Secures Financing Commitment Towards Closing Of Its Option On Canadian Medical Marijuana Facility And Business 10/14/2014
New Irish Tax Rules Won’t Faze Biotech: Analyst 10/14/2014
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc. (GILD) 10/13/2014
Spinal Atrophy Drug From Isis Pharmaceuticals, Inc. (ISIS) Showing Promise, Says UBS 10/13/2014
PRAC Decision On Leukemia Drug Good News For Ariad Pharmaceuticals, Inc. (ARIA), Says Analyst 10/10/2014
DiaGenic ASA: Ex Right To Receive Subscription Rights In The Rights Issue Today, 10 October 2014 10/10/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi 10/9/2014
Skyepharma PLC (SKYEF) – Interim Management Statement 10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO 10/8/2014
Therapix Biosciences ADRs Begin Trading On The OTCQB® 10/7/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
Medtech Startup Embo Medical Secures €3 Million Investment 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
Piper Jaffray: Companies Should Start Stockpiling Now For Ebola 10/3/2014
JSS Medical Research Announces Equity Investment By Capital Croissance PME (CCPME) 10/2/2014
Perrigo Company (PRGO) Announces Extension Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/1/2014
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN) 9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014
GW Pharmaceuticals Research And Development Day Details 9/29/2014
China Cord Blood Corporation To Hold Annual General Meeting In Hong Kong On December 11, 2014 9/26/2014
Antisense Therapeutics Limited (ANP.AX) Release: Placement And Share Purchase Plan 9/25/2014
ProQR Therapeutics B.V. (PRQR) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/24/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
Inivata Raises £4m To Realise The Potential Of Ctdna Analysis To Improve Cancer Treatment Through Simple Blood Tests 9/23/2014
Skyepharma PLC (SKYEF) Announces Notice Of Early Repayment Of Euro CRC Facility 9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million 9/19/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
Ablynx (ABLYF) Establishes Sponsored Level I ADR Programme In The United States 9/5/2014
Horizon Discovery Group Plc: Notice Of Interim Results 9/3/2014
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Medtronic, Inc. (MDT) Announces 2014 "Global Heroes" Team 8/11/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 7/30/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
IntelGenx Corp. To Host Management Call 7/21/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Cantargia’s Share Issue Of 20 MSEK Fully Subscribed 7/9/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014
Vitrolife (VITR.ST) Release: Conference Call Interim Report 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014
TopoTarget A/S Release: Report Pursuant To The Danish Securities Trading Act, Section 28a 7/1/2014
TopoTarget A/S Release: New Articles Of Association Following Capital Increase 7/1/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Shareholders Of Warnex Inc. (CC:WNX) Approve The Amalgamation With Diagnos Inc. (ADK) 6/27/2014
Endo International plc Announces Pricing Of Private Offering Of Senior Notes 6/26/2014
Endo International plc Announces Proposed Private Offering Of Senior Notes 6/25/2014
Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares 6/25/2014
Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014
Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares 6/24/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014
Neovasc Inc. (NVC) Announces Receipt Of Final Approval To Graduate To The TSX 6/20/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue 6/20/2014
BioAlliance Pharma Has Received Pre-Approval For The Secondary Listing Of The Shares Of The Merged Company On NASDAQ OMX Copenhagen 6/20/2014
AstraZeneca PLC (AZN) Release: Director/PDMR Shareholding 6/19/2014
GW Pharmaceuticals Announces Proposed Public Offering Of ADSs 6/18/2014
China Biologic Products Announces Proposed Public Offering Of Common Stock 6/18/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/17/2014
Articles Of Association For Genmab A/S (GEN.CO) 6/16/2014
Grant Of Warrants To Genmab A/S (GEN.CO) Employees 6/13/2014
200,000 Orion Corporation A-Shares Converted Into B-Shares 6/13/2014
Actavis (ACT) Announces Receipt Of Requisite Consents And Expiration Of Consent Solicitations For Forest Laboratories, Inc. (FRX) Senior Notes 6/13/2014
Biohit B-Shares Subscribed With Stock Options I And II 2013 6/12/2014
Aurinia (ISA.TO) To Commence Trading On Toronto Stock Exchange 6/11/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 6/10/2014
Actavis (ACT) Announces Offering Of Senior Unsecured Notes 6/10/2014
Orexo AB (ORXOF) Publishes Bond Prospectus And Applies For Listing Of Its Bond Loan On NASDAQ OMX Stockholm 6/9/2014
Oriola-KD Corporation Recognizes EUR 74 Million Impairment Charge For Russian Pharmaceutical Wholesale Operating Segment 6/5/2014
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 6/5/2014
New Incentive Plans In The H. Lundbeck A/S (LUN.CO) Group 6/4/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 6/3/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/2/2014
Total Number Of Voting Rights And Share Capital In Bavarian Nordic (BAVA.CO) 6/2/2014
Total Number Of Voting Rights And Share Capital In H. Lundbeck A/S (LUN.CO) As Of 31 May 2014 6/2/2014
BioLineRx Ltd. Enters Into Share Purchase Agreement With Lincoln Park Capital 5/30/2014
Number Of Shares And Votes In Orexo AB (ORXOF) 5/30/2014
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 5/29/2014
Report Of Transactions Of Shares And Related Securities Of Bavarian Nordic (BAVA.CO) By Persons Holding Managerial Responsibilities And/Or Persons/Companies Closely Associated With Such 5/29/2014
Bavarian Nordic (BAVA.CO) Issues New Shares In Connection With Exercise Of Warrants 5/27/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 5/27/2014
TopoTarget A/S Release: Notice To Convene Extraordinary General Meeting 5/27/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
Annual General Meeting Of MorphoSys AG Approves All Proposals Of The Company's Management 5/23/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Warrant Programme - New Articles Of Association 5/22/2014
ChinaBio(R) LLC Release: China To Stage Only 100 IPOS During The Rest Of 2014 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
H. Lundbeck A/S (LUN.CO) Increases Its Share Capital By 115,722 Shares (0.0590% Of Outstanding Shares) As A Result Of Employee Warrant Exercise 5/21/2014
Enzymotec Announces An Extraordinary General Meeting Of Shareholders To Approve Its Compensation Policy 5/21/2014
Ablynx (ABLYF) Release: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The "Transparency Law") 5/20/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 5/19/2014
ProSensa Holding N.V. (RNA) Announces Shareholder Meeting 5/19/2014
Royal DSM - Repurchase Of Shares (9 - 15 May 2014) 5/16/2014
Report On Transactions With ALK-Abello A/S B-Shares And Associated Securities By Managerial Staff 5/12/2014
Rafarma Pharmaceuticals Commences Preparation Of Audited Financials 5/12/2014
BioTie Therapies Corp. Interim Report 1 January - 31 March 2014 5/9/2014
Oriola-KD Corporation: Notification On A Change In Ownership 5/9/2014
BioTie Therapies Corp.: Change In The Number Of Votes 5/9/2014
Resolutions From Swedish Orphan Biovitrumi's AGM 5/9/2014
AstraZeneca PLC (AZN) Shares Back On Rise Amid Fresh Bid Speculation 5/8/2014
Resolutions At The Annual General Meetings In Medivir AB (MVRBF) On 8 May 2014 5/8/2014
TopoTarget A/S Announces Interim Report For The Period January 1 - March 31, 2014 5/8/2014
Karo Bio AB Release: Interim Report January-March 2014 5/8/2014
ALK-Abello A/S Release: Three-Month Interim Report (Q1) 2014 5/8/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 7 May 2014 5/8/2014
Announcement Of Transactions With Shares And Linked Securities In H. Lundbeck A/S (LUN.CO) Made By Executives And Their Closely Associated Persons And Legal Entities 5/7/2014
Pluristem Therapeutics (PSTI) To Be Added To New TA Tech-Elite Stock Index In Israel 5/7/2014
Report From Annual General Meeting Of Vitrolife (VITR.ST) 5/6/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 5/6/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Effectiveness Of Registration Statement On Form S-4 5/5/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 2 May 2014 5/5/2014
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 1 May 2014 5/2/2014
Galapagos NV (GLPG.BR) Release: Invitation To The Extraordinary General Shareholders' Meeting To Be Held On 19 May 2014 5/1/2014
Norwegian Cancer Society To Invest Euros 0.5 Million In Vaccibody’s VB10.16 HPV Vaccine 5/1/2014
ALK-Abello A/S Announces An R&D And Business Briefing In NYC On 21 May 5/1/2014
Novo Nordisk A/S (NVO) Increased Operating Profit In Local Currencies By 15% In The First Quarter Of 2014 5/1/2014
Passing Of Zealand Pharma  (ZEAL.CO)’s Annual General Meeting 2014 4/30/2014
Change In The Number Of Shares And Votes In BioInvent (BOVNF) 4/30/2014
Neurosearch A/S (NEUR.CO) – Status Announcement For The Period 1 January To 31 March 2014 4/30/2014
Change Of The Number Of Shares And Votes In Karo Bio AB 4/30/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/30/2014
Total Number Of Voting Rights And Share Capital In Novo Nordisk A/S (NVO) As Of 30 April 2014 4/30/2014
Biotage AB (BIOTa.ST) – Changes In Number Of Shares And Votes 4/30/2014
Merck KGaA (MKGAF.PK): Form 8 (DD) - AZ Electronic Materials S.A. 4/30/2014
Olainfarm Release: Resolutions Of The Annual General Meeting Of Shareholders 4/29/2014
Zealand Pharma  (ZEAL.CO) - Interim Report For Q1 2014 (Un-Audited) 4/29/2014
Orion Corporation Interim Report January-March 2014 4/29/2014
BrainStorm Cell Therapeutics Inc. Announces Exchange Of Outstanding Warrants 4/28/2014
Merck KGaA (MKGAF.PK): Form 8 (DD) - AZ Electronic Materials S.A. 4/28/2014
Biotage AB (BIOTa.ST) Launches Share Buy-Back 4/28/2014
TopoTarget A/S Release: Passing On Annual General Meeting 4/25/2014
Active Biotech AB (BTPC) Interim Report January - March 2014 4/24/2014
Oriola-KD Corporation's Interim Report For 1 January-31 March 2014 4/24/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/23/2014
Novo Nordisk A/S (NVO) - Reduction Of The Share Capital 4/23/2014
Publishing Of Orion Corporation's Interim Report For January-March 2014 On 29 April 2014 4/22/2014
Genovis Annual General Meeting 4/22/2014
Sinovac Biotech Ltd. (SVA) Files 2013 Annual Report On Form 20-F 4/16/2014
Swedish Orphan Biovitrum Publishes Annual Report 2013 4/16/2014
300,000 Orion Corporation A-Shares Converted Into B-Shares 4/15/2014
Report From Orexo AB (ORXOF)’s Annual General Meeting, 15 April 2014 4/15/2014
Decisions Of The Annual General Meeting Of Biohit 4/14/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/14/2014
Active Biotech AB (BTPC) - Notice Of Annual General Meeting Of Shareholders 4/14/2014
Report Of Transactions In Zealand Pharma  (ZEAL.CO)’s Shares And Related Securities By Executives And Their Related Parties 4/11/2014
Vitrolife (VITR.ST) Release: Summary Annual Report 2013 In English 4/11/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Annual Report 2013 4/11/2014
Hansa Medical's Rights Issue Oversubscribed 4/11/2014